Class & Mechanism
PNC-27 is an anticancer peptide that targets the human double minute-2 (HDM-2) protein, also known as murine double minute-2 (MDM-2). HDM-2 is an E3 ubiquitin ligase that negatively regulates the tumor suppressor protein p53 by promoting its ubiquitination and degradation. By binding to HDM-2, PNC-27 inhibits this interaction, thereby stabilizing p53 and enhancing its tumor suppressive activity [33].
Research-documented benefits
Local corpus: silent.
General-knowledge benefits
PNC-27 has been studied for its potential anticancer effects by targeting HDM-2 and stabilizing p53. Preclinical studies have shown that PNC-27 can inhibit the growth of cancer cells, induce apoptosis, and enhance the effectiveness of chemotherapeutic agents in various cancer models [33]. Additionally, PNC-27 has been investigated for its potential to sensitize cancer cells to radiation therapy by promoting DNA damage and apoptosis [33].
Typical injectable protocol
The typical injectable protocol for PNC-27 is not well-established in the literature. However, based on its use in preclinical studies, it is generally administered subcutaneously (SC) or intravenously (IV) in the range of micrograms (µg) per dose, with treatment cycles varying depending on the specific cancer type and the individual's response to therapy.
Key risks / contraindications
As with any peptide therapy, PNC-27 carries a risk of allergic reactions or anaphylaxis. It should not be used in patients with a known hypersensitivity to the peptide or any of its components. Additionally, its safety in pregnant or breastfeeding women is not well-established.
Bottom line
PNC-27 is an anticancer peptide with potential therapeutic benefits in targeting HDM-2 and stabilizing p53 to enhance tumor suppression. Its use is primarily investigational, and further research is needed to fully understand its mechanisms and establish its safety and efficacy profile.
References
- Adenoviruses_ Basic Biology to Gene Therapy
- Advances in drug delivery
- Antioxidants and redox signaling_ impact on NF-κB and Nrf2
- Antisense Research and Application
- Antisense oligonucleotides_ the state of the art
- Biomaterials Science_ An Introduction to Materials in Medicine
- Cancer_ Principles & Practice of Oncology
- Cells, Aging, and Human Disease
- Chemical Biology of Nucleic Acids
- Gene Therapy_ Therapeutic Mechanisms and Strategies
- Gene and Cell Therapy_ Therapeutic Mechanisms and Strategies
- Inclisiran in patients at high cardiovascular risk
- Medicinal Chemistry of Anticancer Drugs
- Mitochondrial Medicine_ Volume II, Manipulating Mitochondrial Function
- Oxidative Stress and Inflammation in Non-communicable Diseases_ Molecular Mechanisms and Perspectives in Therapeutics
- Peptide Bioregulators in Gerontology
- Peptide Therapeutics_ Design and Development
- Peptides and Non Peptides of Oncologic and Endocrine Interest
- Peptides_ Chemistry and Biology, 2nd Edition
- Pharmacology
- Principles and Practice of the Biologic Therapy of Cancer
- Prodrugs_ Challenges and Rewards
- RNA Interference Technology
- RNA Interference_ From Biology to Clinical Applications
- RNA Therapeutics_ Function, Design, and Delivery
- Sirtuins and NAD br sup + sup br
- The Metabolic Role of Phosphate